Company

Vaccentis

Biotechnology Research Ch 6 employees

Employees: 6
Contacts: 2
Emails: 2
Phones: 1

www.vaccentis.com LinkedIn

Vaccentis Overview

Headquarters: Ch
Website: www.vaccentis.com
Industry: Biotechnology Research
Employees: 6
Founded: 2006
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Biotechnologie Onkologie Tumor Vaccine

About Vaccentis

LATE STAGE DEVELOPMENT OF AN PROTEIN-BASED TUMOUR VACCINE FOR RENAL CELL CARCINOMA VCC MEDICAL DIVISION IS DEVELOPING CLINICALLY PROVEN PRODUCTS, SHOWN TO MAINTAIN REMISSION AND ALLEVIATE DISEASE VCC-001 cancer vaccine Phase III data in Renal Cell Cancer has demonstrated clinical effect and was well tolerated, a disease with few current treatment options VCC-001 cancer vaccine platform has significant potential in metastatic renal cell, colon and pancreatic cancers

Vaccentis Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

Vaccentis Org Chart

Sample employees and titles

Name	Title	Location	Contact
Martin Munte	Pharma & Biotech CEO - Expert in General Management - Leadership - Implementation - Business Operations - +25 Years of Experience	Lugano, Ticino, Switzerland	Email Phone
Ingrid Rauter	Head of Research and Development and Chief Medical Officer	Switzerland	Email
Subhasis (Subh) Roy	Life Sciences Executive & Board Member		View
Michael Rossbach, Prof. Dr.	Science-business Professional, Entrepreneur, Investor	Kettenhausen, Rhineland-palatinate, Germany	View